Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

US Memorial Day Weekend Market Analysis

The US Memorial Day weekend is set up to become a very interesting time for investors. The EU voting is complete and the change in EU leadership may move the markets a bit. China appears to be playing a waiting game – attempting to hold the US/Trump at bay until after the 2020...
Chris Vermeulen | June 10, 2019 |

Daily Gold News: Monday, May 25 – Gold Trading Along Last Week’s Lows

The gold futures contract gained 0.79% on Friday as it slightly retraced Thursday decline of 1.7%. On Thursday it extended a downward correction from the last Monday’s new monthly high of $1,775.80. The market has retraced almost all of the decline from Apr...
Paul Rejczak | May 25, 2020 |

Alder BioPharmaceuticals Shares Surge 80% on Acquisition News

Shares of migraine treatment research firm Alder BioPharmaceuticals opened 84% higher today after the company announced that it has agreed to be acquired by H. Lundbeck for $1.95 billion. Early this morning, clinical-stage biopharmaceutical company Alder BioPharmaceu...
Streetwise Reports | September 17, 2019 |

Akcea Therapeutics Inks Worldwide Licensing Deal with Pfizer...

Akcea Therapeutics Inks Worldwide Licensing Deal with Pfizer for Investigative Antisense Therapy, Shares Up 30% Akcea Therapeutics' shares are trading 30% higher today on news that it has entered into a worldwide exclusive licensing agreement with Pfizer for AKCEA-ANG...
Streetwise Reports | October 8, 2019 |

Daily Gold News: Friday, May 22 – Less Volatility Ahead of Long Holiday Weekend

The gold futures contract lost 1.72% on Thursday as it extended a downward correction from Monday’s new monthly high of $1,775.80. The market reached its daily low at $1,715.30 yesterday. On Monday it had retraced almost all of the decline from April 14 hig...
Paul Rejczak | May 22, 2020 |

BioNTech, Evotec, XPhyto - will the next rally start?

Germany's leading index DAX closed the previous day at 11,391 points, its highest level since March 2020. At the beginning of the week the index of the 30 largest German companies gained 317 points compared to Friday, representing a gain of 2.87%. In the USA Wall Street remain...
Mario Hose | May 26, 2020 |

Daily Gold News: Tuesday, May 26 – No Clear Short-Term Direction

The gold futures contract traded within a downward correction from its new monthly high of $1,775.80 last week. It has retraced almost all of the decline from April 14 high of $1,788.80 on Monday, before reversing downwards again. Gold price continues to trade within an ov...
Paul Rejczak | May 26, 2020 |

Dova Pharma Shares Rise 38% on Swedish Firm Takeover Offer

Shares of Dova Pharmaceuticals opened 38% higher today on news that the firm will be acquired by Swedish Orphan Biovitrum. The deal is reportedly valued at $915 million or $29/share. This morning Durham, N.C.-based Dova Pharmaceuticals Inc. (DOVA:NASDAQ) announced ...
Streetwise Reports | October 1, 2019 |

Achillion Pharma Shares Open 75% Higher After Alexion Buyout Offer

Shares of Achillion Pharmaceuticals are trading much higher today after the firm reported that it has agreed to be acquired by Alexion Pharmaceuticals for $930 million, or $6.30 per share in cash, along with the potential for an additional $2 per share if certain other specifi...
Streetwise Reports | October 17, 2019 |

US Stocks Break Downward In Afternoon Trading

The afternoon price breakdown in the YM (Down Futures) continues to confirm our recent analysis. We authored a three-part research post near mid-May discussing how the global tensions would likely play out in the global stock markets. We also authored another, more recent, r...
Chris Vermeulen | June 10, 2019 |
1 2